Related by context. All words. (Click for frequent words.) 69 atypical antipsychotic medications 68 comorbid conditions 68 underdiagnosis 68 psychiatric comorbidities 68 psychiatric comorbidity 68 medication nonadherence 67 severe exacerbations 67 postoperative atrial fibrillation 66 postoperative complication 66 venous thromboembolic disease 66 β blockers 66 OSAHS 66 asthma exacerbations 65 postoperative mortality 65 aldosterone antagonist 65 thiopurine 65 conventional antipsychotics 65 postoperative AF 65 thromboembolic 65 DVT PE 65 comorbidity 65 ß blockers 65 thromboembolism 65 antithrombotic therapy 65 sotalol 65 extrapyramidal symptoms 65 hypoglycemic episodes 64 arterial thromboembolic events 64 carotid stenosis 64 clomipramine 64 depressive symptomatology 64 TEAEs 64 recurrent venous thromboembolism 64 upper gastrointestinal bleeding 64 salmeterol HFA MDI 64 hypoglycaemic episodes 64 beta blocker therapy 64 neurocognitive deficits 64 Polypharmacy 64 Suicidal ideation 64 TMP SMX 64 systolic hypertension 64 psychiatric morbidity 64 chlamydial infection 64 noncardiac 64 venlafaxine Effexor 64 Cognitive impairment 64 subclinical atherosclerosis 64 somatoform disorders 64 nonfasting triglyceride levels 64 fluoxetine Prozac 64 virologic failure 64 invasive aspergillosis 64 guideline concordant 64 postoperative pulmonary 63 antioxidant supplementation 63 periprocedural MI 63 atherothrombotic disease 63 untreated psychosis 63 asymptomatic PAD 63 Hypotension 63 autonomic dysfunction 63 paroxysmal AF 63 recurrent VTE 63 comorbid disorders 63 suboptimal adherence 63 lipid lowering agents 63 thromboprophylaxis 63 NNT = 63 glomerular filtration 63 macrovascular events 63 perioperative complications 63 polypharmacy 63 oral anticoagulation 63 lipid lowering medications 63 chronicity 63 paroxetine Paxil 63 suicide attempters 63 nonvertebral fractures 63 Antipsychotic 63 somatic symptoms 63 comorbid depression 63 neuroleptic 63 antipsychotic prescribing 63 neuropsychiatric symptoms 63 vaginal hysterectomy 63 poor metabolizers 63 dysthymia 63 recurrent ischemia 63 hyperkalemia 63 cranial irradiation 63 atherogenic dyslipidemia 63 thrombotic complications 63 thromboembolic disease 63 androgen deficiency 63 HER2 overexpression 63 abdominal adiposity 63 cerebrovascular events 63 univariate analyzes 62 antidiabetic medication 62 subclinical hypothyroidism 62 poststroke depression 62 APTIVUS r 62 untreated OSA 62 Venous thromboembolism 62 SRBD 62 postoperative complications 62 vitamin D inadequacy 62 Heritability 62 Major Depressive Disorder 62 hyperprolactinemia 62 prodromal symptoms 62 HbA 1c levels 62 hypoglycemic events 62 COPD exacerbations 62 perioperative mortality 62 postdischarge 62 hemorrhagic complications 62 CYP#D# inhibitor 62 NIHSS score 62 virological failure 62 nonvertebral fracture 62 oral antidiabetes 62 neuroleptics 62 pharmacologic treatments 62 multivariate adjustment 62 neurologic sequelae 62 nonfatal MI 62 Comorbid 62 cardiac toxicity 62 syncopal 62 QTc intervals 62 divalproex sodium 62 platelet reactivity 62 potentially modifiable 62 cerebral vasospasm 62 periprocedural 62 anastomotic leak 62 severe hypoglycaemia 62 suicide ideation 62 nonpharmacologic 62 LV dysfunction 62 serum creatinine levels 62 CPAP adherence 62 antimicrobial prophylaxis 62 antihypertensive therapy 62 opioid misuse 62 Nonadherence 62 neonatal morbidity 62 rebleeding 62 postoperative infections 62 sociodemographic characteristics 62 Vitamin D insufficiency 62 dysglycemia 62 recurrent miscarriage 62 CVD mortality 62 VTE prophylaxis 62 lipid lowering therapy 61 T2DM 61 gastrointestinal GI bleeding 61 glucocorticoid therapy 61 noncardiovascular mortality 61 uncontrolled asthma 61 dysfunctional voiding 61 ICD implantation 61 overactive bladder symptoms 61 Vitamin B# deficiency 61 microalbuminuria 61 androgen suppression 61 postprocedure 61 depressive symptom 61 reinfarction 61 affective disorders 61 SSRI antidepressant 61 antibiotic prophylaxis 61 TNF antagonist 61 morphometric vertebral fractures 61 generalized epilepsy 61 HIV HCV coinfected 61 posttraumatic stress disorder PTSD 61 Personality disorders 61 hypovitaminosis D 61 meta regression 61 multivariable analysis 61 hyperglycaemia 61 antithrombotics 61 atherothrombotic 61 Hepatotoxicity 61 baseline HbA1c 61 reflux symptoms 61 decompensated heart failure 61 Generalized Anxiety Disorder 61 comorbid psychiatric 61 prescribed opioids 61 severe hypoglycemia 61 Exacerbations 61 GnRH agonists 61 glycated hemoglobin levels 61 perioperative morbidity 61 recurrent tonsillitis 61 thrombotic events 61 perioperatively 61 NATRECOR ® 61 akathisia 61 comorbid 61 polyp recurrence 61 Prehypertension 61 prospectively stratified 61 familial aggregation 61 thrombophilia 61 pulmonary dysfunction 61 Genetic predisposition 61 primary aldosteronism 61 oxycodone CR 61 HF hospitalization 61 hepatotoxicity 61 bronchial hyperresponsiveness 61 ziprasidone 61 familial clustering 61 trimethoprim sulfamethoxazole 61 Nesiritide 61 parkinsonian symptoms 61 intravenous bisphosphonates 61 psychosocial variables 61 venlafaxine XR 61 nonpsychiatric 61 microscopic hematuria 61 Cardiotoxicity 61 OAB symptoms 61 mitochondrial toxicity 61 aldosterone antagonists 61 postoperative delirium 61 dopaminergic therapy 61 Subgroup analyzes 61 venous thromboembolism 61 neurocognitive impairment 61 postintervention 61 corticosteroid therapy 61 elevated ALT 61 postoperative morbidity 61 carotid IMT 61 severe asthma exacerbations 61 antiepileptics 61 reoperations 61 newer atypical antipsychotics 61 systemic corticosteroid 61 albumin excretion 61 rhinoconjunctivitis 61 premorbid 61 CYP #A# 61 Generalized anxiety disorder 61 revascularizations 61 prolactin levels 61 asthma exacerbation 61 symptomatic VTE 61 CP CPPS 61 suicidality 60 renal scarring 60 tryptophan depletion 60 virological response 60 GH deficiency 60 Heavy menstrual bleeding 60 anticoagulation therapy 60 attain statistical significance 60 androgen deprivation 60 comorbidities 60 arterial thickening 60 pCR 60 typical antipsychotics 60 DMARD 60 fragility fracture 60 ADEs 60 T1DM 60 elevated IOP 60 randomized controlled trials RCTs 60 intensive statin therapy 60 BENICAR HCT 60 spontaneous preterm delivery 60 antiplatelet medications 60 chronic rhinosinusitis 60 systolic dysfunction 60 IPAH 60 nonoperative treatment 60 beta carotene supplementation 60 hyperalgesia 60 fetal malformations 60 advanced neoplasia 60 somatization disorder 60 subclinical disease 60 adrenal insufficiency 60 PRADAXA 60 PASI scores 60 unmeasured confounders 60 MGUS 60 analgesic medications 60 silent myocardial ischemia 60 HeFH 60 angiotensin converting enzyme inhibitors 60 Postoperative complications 60 cerebral microbleeds 60 euthymic 60 CYP#C# [001] 60 subtrochanteric 60 hypomanic episodes 60 intravenous diuretics 60 glycated hemoglobin HbA1c 60 venous thrombosis 60 bacterial prostatitis 60 cerebral oxygenation 60 hippocampal atrophy 60 haematologic 60 empiric therapy 60 treatment emergent AEs 60 elevated CRP 60 EXJADE 60 de ath 60 coronary revascularization 60 colorectal adenoma 60 amenorrhoea 60 nondiabetic patients 60 VaD 60 S. aureus colonization 60 recurrent preterm birth 60 airflow limitation 60 potassium sparing diuretics 60 antenatal depression 60 definite stent thrombosis 60 NATRECOR R 60 sacral neuromodulation 60 advanced adenoma 60 loop diuretics 60 intracranial stenosis 60 Erythropoietic therapies may 60 COPD exacerbation 60 postoperative chemotherapy 60 Adjuvant chemotherapy 60 serum phosphate 60 acromegalic patients 60 adrenal suppression 60 elevated bilirubin 60 ALT flares 60 posttransplant 60 SLNB 60 induce orthostatic hypotension 60 neurologic complications 60 venous blood clots 60 obstetric complications 60 endometrial hyperplasia 60 intracranial hemorrhage ICH 60 hypercalciuria 60 untreated sleep apnea 60 rehospitalization 60 gastrointestinal adverse reactions 60 inhospital 60 malabsorptive 60 cholinergic tone 60 hypochondriasis 60 methotrexate monotherapy 60 serum urate levels 60 microvascular disease 60 contrast induced nephropathy 60 colorectal neoplasia 60 Comorbidities 60 ICD shocks 60 pyridostigmine 60 fluoxetine paroxetine 60 MADRS score 60 variceal bleeding 60 p = #.# [003] 60 urolithiasis 60 pharmacological therapy 60 hematologic toxicity 59 serotonin reuptake inhibitors 59 AUDs 59 coexisting illnesses 59 MMSE scores 59 symptomatic hyponatremia 59 poststroke 59 postsurgical complications 59 proliferative diabetic retinopathy 59 genotypic resistance 59 hematologic abnormalities 59 sertraline Zoloft 59 thiazide 59 improves glycemic 59 affective psychoses 59 ALT elevations 59 neurodevelopmental outcomes 59 ofpatients 59 atypical femur fractures 59 HSCT 59 salmeterol fluticasone 59 undergoing CABG 59 abnormal lipids 59 MMSE score 59 antimuscarinic 59 fragility fractures 59 nocturnal enuresis 59 renal impairment 59 quetiapine Seroquel 59 dyslipidaemia 59 euthymic patients 59 neuropsychological impairments 59 Nocturia 59 concomitant medications 59 myocardial ischaemia 59 CLBP 59 aneurysmal subarachnoid hemorrhage 59 bezafibrate 59 paroxetine sertraline 59 prostate cancer CaP 59 risperidone Risperdal 59 bowel resection 59 platelet inhibition 59 thromboembolic events 59 comorbid illnesses 59 antidiabetic drugs 59 subclinical hyperthyroidism 59 agomelatine 59 daytime drowsiness 59 testosterone supplementation 59 comorbid anxiety 59 Scale EDSS score 59 nonoperative 59 AA Amyloidosis 59 hyperhomocysteinemia 59 CIMZIA ™ 59 LUTS 59 syndromal 59 detrusor overactivity 59 HbA1c levels 59 antihypertensive medications 59 HPA axis suppression 59 hepatic fibrosis 59 conventional DMARDs 59 hepatic toxicity 59 sustained virological response 59 annualized relapse 59 mild renal insufficiency 59 patients undergoing CABG 59 pentoxifylline 59 interpersonal psychotherapy 59 thromboembolic complications 59 thyrotropin levels 59 renal flares 59 methimazole 59 dysmenorrhoea 59 gallstone disease 59 anovulation 59 TZDs 59 dose statin therapy 59 ruptured aneurysms 59 MetS 59 non pharmacological interventions 59 atrophic gastritis 59 neuropsychological deficits 59 A1c levels 59 acarbose 59 lipid lowering drugs 59 Hb A1C 59 ACEIs 59 statins cholesterol lowering 59 CRBSI 59 cerebral infarction 59 BEXXAR Therapeutic Regimen 59 morbidity mortality 59 HbA1C levels 59 CYP#C# genotype 59 aminotransferases 59 tumor histology 59 cardiovascular mortality 59 POAG 59 left ventricular dysfunction 59 albumin excretion rate 59 probiotic supplementation 59 EDSS scores 59 ziconotide 59 loop diuretic 59 adenoidectomy 59 renoprotective 59 hypoxemia 59 unipolar depression 59 elevated triglyceride levels 59 hematopoietic cancers 59 neurocognitive functioning 59 glycosylated hemoglobin HbA1c 59 Depressive symptoms 59 metabolic dysregulation 59 CTEPH 59 hypercholesterolaemia 59 Y BOCS 59 ADHF 59 lactic acidosis 59 cardiac dysfunction 59 serum calcium 59 myocardial ischemia 59 sideeffects 59 antiarrhythmic drug 59 myopathy rhabdomyolysis 59 adenoma recurrence 59 interindividual variability 59 AChE inhibitors 59 topical NSAIDs 59 maximal doses 59 cardiac insufficiency 59 mania hypomania 59 PONV 59 IOP lowering 59 hsCRP levels 59 Candesartan 59 oral prednisolone 59 generalizability 59 HER2 expression 59 colorectal liver metastases 59 antiplatelet drugs 59 virologic response 59 vestibular dysfunction 59 adjuvant therapies 59 anticonvulsant medications 59 pharmacologic intervention 59 postmenopausal hormone replacement 59 Sociodemographic 59 onset atrial fibrillation 59 methodological limitations 59 antiemetics 59 VADT 59 undertreatment 59 MS relapses 59 CHD CVD 59 urinary cortisol 59 Calcium intake 59 chronic LBP 59 Index CDAI 59 cytopenias 59 antibiotic regimens 59 shorter telomere length 58 Venous Thromboembolism 58 SCr 58 bronchopulmonary dysplasia 58 warfarin therapy 58 vesicoureteral reflux 58 stable angina 58 CHD mortality 58 candidemia 58 intracerebral haemorrhage 58 Charlson comorbidity index 58 residual confounding 58 Topical corticosteroids 58 invasive fungal infection 58 neuroleptic drugs 58 advanced adenomas 58 syncopal episode 58 ischemic cardiomyopathy 58 familial AF 58 androgen ablation 58 modifiable risk 58 neurocognitive function 58 impaired cognition 58 Parnate 58 treat NNT 58 symptomatic aortic stenosis 58 adverse cytogenetics 58 BRCA testing 58 Aortic stenosis 58 Prostatitis 58 liver metastasis 58 delayed gastric emptying 58 citalopram Celexa 58 abnormal lipid 58 dalteparin 58 coronary stenosis 58 venous thromboembolic events 58 androgen excess 58 INVEGA ® 58 nicardipine 58 NPH insulin 58 depressive illnesses 58 airway hyperresponsiveness 58 renal toxicity 58 DHEA supplementation 58 alexithymia 58 myocardial infarctions MIs 58 Zevalin consolidation 58 internalizing disorders 58 droperidol 58 HBeAg seroconversion 58 amisulpride 58 invasive candidiasis 58 digoxin toxicity 58 protease inhibitor mutations 58 atherothrombosis 58 anthracycline therapy 58 asymptomatic carotid stenosis 58 QTc prolongation 58 metabolic derangement 58 VAPRISOL 58 recurrent DVT 58 SGAs 58 cirrhotic patients 58 Chronic insomnia 58 pharmacokinetic interactions 58 myocardial fibrosis 58 tricyclics 58 COREG 58 multivariable adjusted 58 initiating HAART 58 Cognitive Impairment 58 clinically meaningful reductions 58 hyperammonemia 58 acid suppressing 58 hemoglobin A1c levels 58 STRIDE PD 58 idraparinux 58 % CI #.#-#.# [008] 58 proliferative retinopathy 58 thiazides 58 somatostatin analogs 58 carotid plaques 58 Toxicities 58 HbA 1c 58 pharmacological interventions 58 DULERA 58 empiric treatment 58 nonpsychotic 58 prescription opioid 58 nonadherent 58 lipid abnormalities 58 comorbid diagnoses 58 CCyR 58 overt nephropathy 58 Recurrences 58 repeat revascularization 58 CMV infection 58 hemodilution 58 cilostazol 58 hyperoxaluria 58 nocturnal hypoglycemia 58 tricyclic antidepressants 58 HAM D# 58 pharmacological intervention 58 chlorthalidone 58 elevated LDL cholesterol 58 nephrotoxicity 58 asymptomatic bacteriuria 58 spirometric 58 Doxil ® 58 anticholinergic effects 58 dopamine antagonists 58 postoperative infection 58 Compulsive hoarding 58 HbA 1C 58 prolonged QT interval 58 induced akathisia 58 severe renal impairment 58 tiagabine 58 MoxDuo TM IR 58 subclinical cardiovascular disease 58 postoperative hemorrhage 58 Non inferiority 58 peginterferon 58 omeprazole Prilosec 58 ticlopidine 58 anticholinergic medications 58 certolizumab 58 rFVIIa 58 affective psychosis 58 confidence interval #.#-#.# 58 ventricular dysfunction 58 prognostic variables 58 pediatric bipolar disorder 58 Excessive daytime sleepiness 58 macroalbuminuria 58 ATACAND 58 psychiatric outpatients 58 lipid elevations 58 hemodialysis patients 58 plasma homocysteine levels 58 Antipsychotics 58 sleep apneas 58 pretest probability 58 hyperactivity inattention 58 androgen depletion 58 paricalcitol 58 univariate analysis 58 immunosuppressive medications 58 developmental neurotoxicity 58 tapentadol ER 58 symptomatology 58 VT VF 58 stratifying patients 58 tranylcypromine 58 NUCYNTA ™ 58 nitrofurantoin 58 dysrhythmias 58 proteinuria 58 colorectal adenomas 58 MULTAQ 58 SSRI SNRI 58 SSRI citalopram 58 CR nPR 58 spontaneous preterm birth 58 Febrile neutropenia 58 preoperative chemotherapy 58 oxcarbazepine 58 abnormal mammograms 58 secondary efficacy endpoint 58 nonmelanoma skin cancers 58 hypercalcemia 58 lipid lowering medication 58 Social Phobia 58 Hurthle cell 58 HRQL 58 RLS symptoms 58 premenstrual syndrome PMS 58 nociceptive pain 58 Effexor venlafaxine 58 CLA supplementation 58 renal artery stenosis 58 chronic prostatitis chronic 58 renal cysts 58 opioid overdose 58 revascularization procedures 58 systemic corticosteroids 58 HGPIN 58 angiotensin II receptor blockers 58 Uncontrolled hypertension 58 candesartan 58 carotid artery narrowing 58 nonmelanoma skin cancer 58 adjuvant systemic 58 underlying pathophysiology 58 KETEK 58 antibiotic rifaximin 58 HIV lipodystrophy 58 bivariate analysis 58 Suicidality 58 neurodevelopmental impairment 58 mycophenolate mofetil 58 hypercoagulable 58 somatoform disorder 58 neurodevelopmental outcome 58 vertebral fracture 58 Hypercholesterolemia 58 RYGB 58 HbA1C 58 serum calcium levels 58 opioid dependent 58 angiographic outcomes 58 LHRH agonists 58 carotid artery blockage 58 thyroid nodules 58 BRCA carriers 58 Teriflunomide 58 adalimumab 58 haloperidol Haldol 58 PSADT 58 gout flares 58 RISPERDAL ® 58 R0 resection 58 hyperparathyroidism 58 newer antipsychotics 58 HAV infection 58 eplerenone 58 coronary calcification 58 tipranavir ritonavir 58 familial pancreatic cancer 58 placenta accreta 58 viral etiology 58 monoclonal gammopathy 58 adrenal function 58 p = .# [002] 58 thyroid dysfunction 58 Secondhand smoke exposure 58 anticholinergic drugs 58 gestational diabetes mellitus 58 serum estradiol 58 DES implantation 58 hypoperfusion 58 Sleep disordered breathing 58 DFMO 57 underwent CABG 57 oral corticosteroids 57 lichen planus 57 fluid overload 57 hypertension diabetes mellitus 57 status epilepticus 57 juvenile idiopathic arthritis 57 prednisone prednisolone 57 immunosuppressive regimen 57 solifenacin 57 neurologic dysfunction 57 serotonin deficiency 57 graft dysfunction 57 fibrinolysis 57 BYSTOLIC 57 posttreatment 57 artery stenosis 57 coagulopathy 57 VIIBRYD 57 QT interval prolongation 57 Arch Intern Med 57 Major depressive disorder 57 PLMs 57 amenorrhea 57 BRCA2 mutation carriers 57 thyrotropin 57 Dyslipidemia 57 depression suicidal ideation 57 sonographic diagnosis 57 alkalosis 57 prostate carcinogenesis 57 Proteinuria 57 IGFD 57 symptomatic intracranial 57 hyperacute 57 acute gout flares 57 tumor necrosis 57 polyarticular 57 adenotonsillectomy 57 mg BID dose 57 APOE genotype 57 generalized seizures 57 Medication adherence 57 montelukast 57 bicuspid aortic valves 57 aminotransferase levels 57 multifactorial 57 recurrent UTI 57 quetiapine 57 anticholinergic agents 57 extracolonic findings 57 riociguat 57 nonresponders 57 Subgroup analysis 57 diabetic kidney 57 aripiprazole 57 follicular lymphomas 57 gonococcal infections 57 etiological 57 moderate renal impairment 57 reperfusion therapy 57 diabetes mellitus DM 57 antidepressant therapy 57 ACE Inhibitors 57 antiplatelet therapies 57 etiologic 57 Nonspecific 57 dentinal hypersensitivity 57 histological subtype 57 atherosclerotic progression 57 radioiodine therapy 57 metastatic RCC 57 diastolic heart 57 hypocalcemia 57 lipid lowering therapies 57 MACCE 57 CDI recurrence 57 intact parathyroid hormone 57 intravesical therapy 57 Hip fracture 57 MBCT 57 serum folate concentrations 57 hypersomnia 57 spontaneous bacterial peritonitis 57 interferon ribavirin 57 corticosteroid dose 57 ICD therapy 57 subsyndromal 57 Infusion Reactions Severe 57 decompensation 57 depot antipsychotics 57 DMARDs 57 EFFEXOR XR 57 adjunctive placebo 57 HNPCC 57 testicular tumors 57 glitazones 57 Stent thrombosis 57 divalproex 57 pharmacological therapies 57 KIF6 carriers 57 transaminase levels 57 subgroup analyzes 57 Adenomas 57 incontinence episodes 57 urinary symptoms 57 fluvastatin 57 inhospital mortality 57 inpatient hospitalization 57 microbleeds 57 thiazide diuretics 57 curative resection 57 cardiac autonomic 57 adenomatous polyps 57 syndromic 57 ertapenem 57 moderately emetogenic 57 depressive disorders 57 coadministration 57 cerebral infarctions 57 hemorrhagic strokes 57 VUR 57 DMARDS 57 baseline FEV 57 aldosterone antagonist therapy 57 depressive symptoms 57 nonfasting triglycerides 57 Topiramate 57 Retreatment 57 Comorbidity 57 Hyperlipidemia 57 recurrent abdominal pain 57 ischemic complications 57 atypical antipsychotic drugs 57 electrophysiologic 57 generation antipsychotics 57 PNH patients 57 anemia hemoglobin 57 meta analytic 57 anagrelide 57 confounding variables 57 renal dysfunction 57 rimonabant #mg 57 mL/min/#.# m 2 57 arteriography 57 sociodemographic factors 57 transferrin saturation 57 C. difficile colitis 57 Decompensated Heart Failure 57 conditional logistic regression 57 anticoagulant warfarin 57 acute aortic dissection 57 radicular pain 57 platelet activation 57 glitazone 57 atypicals 57 elevated LDH 57 methodologic 57 LQTS 57 Brugada syndrome 57 sustained virologic response 57 malignant neoplasm 57 plasma cortisol 57 coronary revascularizations 57 atypical ductal hyperplasia 57 hepatic cirrhosis 57 postprandial glycemia 57 Suicidal thoughts 57 symptomatic pulmonary embolism 57 serum potassium 57 progressive dyspnea 57 psychosocial stressors 57 antihypertensive agents 57 dysthymic disorder 57 antihypertensive drugs 57 SGPT 57 neurologic symptoms 57 interferon therapy 57 MIRAPEX 57 acute myocardial infarction MI 57 binary restenosis 57 intracranial hypertension 57 Psychosomatic Research 57 elective PCI 57 strong CYP#A# inducers 57 neutrophil counts 57 metformin monotherapy 57 elevated creatinine 57 LTBI 57 undergoing radical prostatectomy 57 QVAR R 57 nephron sparing surgery 57 antiplatelet therapy 57 obstructive sleep 57 Tumor Response 57 oncologic outcomes 57 NIASPAN 57 dose atorvastatin 57 antidepressive 57 chronic thromboembolic pulmonary 57 psychiatric hospitalization 57 acute GVHD 57 hyperglycemia 57 AMOR IPAT 57 left ventricular diastolic 57 hepatic insufficiency 57 chromosomal rearrangement 57 EoE 57 compulsive hoarding syndrome 57 metabolic acidosis 57 urinary incontinence UI 57 STEP BD 57 Afib 57 resynchronization therapy 57 antiphospholipid syndrome 57 lumbar disk herniation 57 anticholinergic medication 57 ALI ARDS 57 hyperbilirubinemia